Stay updated on Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a minor update to the page's documentation or metadata. This change does not modify study details, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-07-04T13:21:17.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.6.2 has been added and Revision: v3.6.0 has been removed. This indicates an update to the page's documentation rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-06-27T07:43:20.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Enrollment status now indicates that recruitment has closed. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and there were minor header/revision text updates.
    Difference
    0.1%
    Check dated 2026-06-13T01:00:00.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site's revision marker changed from v3.5.4 to v3.5.5, indicating an updated release of the platform. This change does not modify the study page content.
    Difference
    0.0%
    Check dated 2026-06-05T22:45:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4, representing a minor update to the study record rather than a substantive change to its content.
    Difference
    0.0%
    Check dated 2026-05-15T12:33:52.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Updated the Chile site’s location labeling (Araucania/Temuco) by replacing Spanish “Región de la Araucanía” wording with “Araucania,” and updated the page’s revision footer from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.